Valor202020212022202320242025TTMGastos comerciales, generales y administrativos16.47 M22.94 M18.05 M14.51 M9.64 M7 M7 MInvestigación y desarrollo7.96 M3.89 M1.51 M1.39 M53 K9 0009 000Beneficio operativo-12.78 M-35.53 M-18.82 M-13.94 M-3.65 M-2.5 M-2.5 MTotal de ingresos no operativos18.37 M10.11 M2.31 M48 K31 K4.61 M2.31 MGastos por intereses, netos de intereses capitalizados47 K20 K—————Ingresos no operativos, una vez deducidos los gastos por intereses17.58 M-20 K2.28 M002.3 M0Ingresos/gastos extraordinarios740 K10.11 M33 K48 K31 K2.31 M2.31 MBeneficio antes de impuestos-6.15 M-16.13 M-15.6 M-13.16 M-4.31 M-2.33 M-685 KParticipación en los beneficios———————Impuestos-124 K2 00014 K8 0008 0008 000—Participación minoritaria-1.37 M-1.47 M-236 K-5 0000——Otros ingresos/gastos después de impuestos———————Beneficio neto antes de actividades interrumpidas-4.66 M-14.66 M-15.38 M-13.16 M-7.04 M-2.34 M-2.34 MOperaciones suspendidas———-821 K———Beneficio neto-4.66 M-14.66 M-15.38 M-13.98 M-7.04 M-2.34 M-2.34 MAjuste por dilución———————Dividendos de las acciones preferentes———————Beneficio neto diluido atribuible a los accionistas-4.66 M-14.66 M-15.38 M-13.98 M-7.04 M-2.34 M-2.34 MBeneficio básico por acción——-25.65-11.3-5.17-1.71-1.71Beneficio por acción diluido——-25.65-11.3-5.17-1.71-1.71Número medio de acciones ordinarias——599.39 K1.24 M1.36 M1.37 M5.47 MAcciones diluidas——599.39 K1.24 M1.36 M1.37 M5.47 MEBITDA-16.47 M-34.48 M-18.05 M-12.96 M-2.81 M-2.25 M-2.25 MEBIT-17.09 M-35.53 M-18.53 M-13.24 M-2.87 M-2.28 M-2.28 MCosto de los ingresos4.31 M8.71 M9.8 M3.3 M2.96 M3.1 M3.1 MOtros costes de producción4.31 M—2.47 M444 K154 K0—Amortización y depreciación (flujo de caja)618 K1.04 M479 K287 K58 K32 K32 K
Arcadia Biosciences Inc
Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.
It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought.